Michael Agius

Title: Michael Agius: Innovator in Proteolysis Targeting Chimeric Molecules

Introduction

Michael Agius is a prominent inventor based in Boston, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of innovative compounds that target dysregulated proteins for degradation.

Latest Patents

Agius holds a patent for "Proteolysis targeting chimeric molecules (PROTACs) with functional handles and uses thereof." This patent discloses multifunctional compounds, conjugates, macromolecules, and polymers designed to target dysregulated proteins for degradation. Additionally, it includes methods of preparation, compositions, kits, and methods of use related to these degraders.

Career Highlights

Throughout his career, Michael Agius has worked with esteemed institutions such as the Massachusetts Institute of Technology and Dana-Farber Cancer Institute Inc. His work has been pivotal in advancing research in the field of protein degradation.

Collaborations

Agius has collaborated with notable individuals in his field, including Jeremiah Allen Johnson and Hung Vanthanh Nguyen. Their combined expertise has contributed to the success of his innovative projects.

Conclusion

Michael Agius is a key figure in the development of proteolysis targeting chimeric molecules, with a focus on creating effective solutions for targeting dysregulated proteins. His contributions to biotechnology continue to influence the field significantly.